Pharmacist‑led Telepharmacy and remote counselling expanded rapidly after 2020, driven by pandemic‑era service redesign and wider adoption of telehealth platforms. Evidence suggests potential benefits for medication adherence, safety, and access, but implementation, equity, and outcome measurement remain heterogeneous across India and other LMICs. To systematically map and synthesize evidence from 2020–2026 on the effects, implementation factors, and equity outcomes of pharmacist‑led Telepharmacy and remote patient counselling in India and comparable LMIC settings. Placeholder numbers — replace with your extracted results before submission: X studies met inclusion criteria (Y studies from India), comprising N participants and M implementation reports. Across included studies, pharmacist‑led Telepharmacy interventions were associated with improvements in medication adherence in most controlled studies (standardized mean difference or relative improvement to be reported), reductions in DRPs or medication errors in several implementation evaluations, and mixed effects on readmissions. Patient satisfaction and acceptability were generally high where measured, but access and equity findings highlighted a persistent digital divide (rural, low‑literacy, and low‑income groups underrepresented). Heterogeneity in intervention models, outcome measures, and study quality limited pooled estimates for some outcomes. Cost-effectiveness, and prioritize implementation studies that address di Pharmacist‑led Tele pharmacy and remote counselling show promise for improving adherence, medication safety, and patient satisfaction in India and LMIC contexts, but evidence is limited by heterogeneity and gaps in equity‑focused reporting. Future research should standardize core outcomes, evaluate digital access, training, and regulatory barriers to support scalable, equitable Telepharmacy services.
Harshavardhan et al. (Tue,) studied this question.